Achieve Life Sciences, Inc. (ACHV) News
Follow Achieve Life Sciences, Inc. (ACHV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Achieve Life Sciences Initiated at Buy by Stifel
Ratings actions from Benzinga
NEWS | Sep 30, 2026, 09:44 AM UTC
L
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
SEATTLE and VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. NASDAQ:ACHV, a late-stage specialty pharmaceutical company focused on the global development and commercialization o
NEWS | Sep 28, 2026, 12:32 PM UTC
L
Achieve Life Sciences announces new-hire inducement awards grant
Achieve Life Sciences, Inc. said it announced granting of new hire inducement awards to support hiring.
EQUITY | Sep 03, 2026, 09:17 PM UTC
L
ACHV - Achieve Life Sciences Announced Granting of New Hire Inducement Awards
ACHV - Achieve Life Sciences Announced Granting of New Hire Inducement Awards
EQUITY | Sep 03, 2026, 09:15 PM UTC
L
Analysts initiate coverage on ACHV, ALGM, KZIA, MTSI, PLYX, SBSW
Several brokers initiate or reiterate bullish coverage on ACHV, ALGM, KZIA, MTSI, PLYX and SBSW, including overweight, buy and strong buy ratings.
EQUITY | Aug 13, 2026, 10:50 AM UTC
L
ACHV Appoints New Leaders
ACHV appoints new leaders for CMC, supply chain, and quality
EQUITY | Aug 03, 2026, 12:31 PM UTC
L
ACHV Grants New Hire Inducement Awards
ACHV grants new hire inducement awards
EQUITY | Jul 31, 2026, 12:30 PM UTC
H
Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Nasdaq 100 futures gaining around 100 points on Wednesday. Shares of Phoenix Education Partners Inc (NYSE: PXED ) fell sharply in pre-market trading after the
EARNINGS | Jul 15, 2026, 12:02 PM UTC
L
ACHV Cytisinicline's CRL was released by FDA, and no surprises with Q426 resubmission still planned; BUY, $13 PT @ Canaccord
ACHV Cytisinicline's CRL was released by FDA, and no surprises with Q426 resubmission still planned; BUY, $13 PT @ Canaccord
REGULATION | Jul 14, 2026, 12:17 PM UTC
H
ACHV: Receives FDA Response
Achieve Life Sciences Receives FDA's Complete Response Letter Regarding New Drug Application For Cytisinicline; FDA Identifies No Deficiencies Regarding Clinical Efficacy, Safety Of Cytisinicline
REGULATION | Jun 22, 2026, 12:35 PM UTC
H
ACHV Receives FDA Letter
ACHV - Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
REGULATION | Jun 22, 2026, 12:30 PM UTC